{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:23:30Z","timestamp":1790785410817,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10-11","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science and Technology Major Project of China","award":["2017ZX10202203"],"award-info":[{"award-number":["2017ZX10202203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00011-022-01629-4","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T18:02:40Z","timestamp":1663437760000},"page":"1389-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis"],"prefix":"10.1007","volume":"71","author":[{"given":"Junwei","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"1629_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, et al. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601\u201313.","journal-title":"Cell"},{"issue":"28","key":"1629_CR2","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1126\/sciimmunol.aar7754","volume":"3","author":"T Fabre","year":"2018","unstructured":"Fabre T, Molina MF, Soucy G, Goulet JP, Willems B, Villeneuve JP, et al. Type 3 cytokines IL-17A and IL-22 drive TGF-beta-dependent liver fibrosis. Sci immunol. 2018;3(28):7754.","journal-title":"Sci immunol"},{"key":"1629_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.603649","volume":"12","author":"S Mountford","year":"2021","unstructured":"Mountford S, Effenberger M, Noll-Puchta H, Griessmair L, Ringleb A, Haas S, et al. Modulation of liver inflammation and fibrosis by interleukin-37. Front Immunol. 2021;12: 603649.","journal-title":"Front Immunol"},{"key":"1629_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209\u201318.","journal-title":"J Clin Investig"},{"issue":"11","key":"1629_CR5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/cmi.2017.72","volume":"14","author":"H Peng","year":"2017","unstructured":"Peng H, Sun R. Liver-resident NK cells and their potential functions. Cell Mol Immunol. 2017;14(11):890\u2013294.","journal-title":"Cell Mol Immunol"},{"key":"1629_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13054-020-02977-5","volume":"24","author":"M Li","year":"2020","unstructured":"Li M, Li C, Wu X, Chen T, Ren L, Xu B, et al. Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis. Crit Care. 2020;24:268.","journal-title":"Crit Care"},{"key":"1629_CR7","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1038\/s41598-021-83496-3","volume":"11","author":"JW Park","year":"2021","unstructured":"Park JW, Jung KH, Lee JH, Moon SH, Cho YS, Lee KH. (89)Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells. Sci Rep. 2021;11:3876.","journal-title":"Sci Rep"},{"key":"1629_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37:1\u201310.","journal-title":"Semin Liver Dis"},{"key":"1629_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ebiom.2018.11.055","volume":"39","author":"F Dong","year":"2019","unstructured":"Dong F, Jiang S, Li J, Wang Y, Zhu L, Huang Y, et al. The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway. EBioMedicine. 2019;39:472\u201383.","journal-title":"EBioMedicine"},{"key":"1629_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41598-017-18305-x","volume":"8","author":"M Wammers","year":"2018","unstructured":"Wammers M, Schupp AK, Bode JG, Ehlting C, Wolf S, Deenen R, et al. Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids. Sci Rep. 2018;8:255.","journal-title":"Sci Rep"},{"key":"1629_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958\u201369.","journal-title":"Nat Rev Immunol"},{"key":"1629_CR12","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.3748\/wjg.15.3329","volume":"15","author":"H Bernstein","year":"2009","unstructured":"Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15:3329\u201340.","journal-title":"World J Gastroenterol"},{"key":"1629_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2147\/JIR.S298495","volume":"14","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Yue C, Zhang H, Chen H, Liu Y, Li J. Deoxycholic acid and lithocholic acid alleviate liver injury and inflammation in mice with klebsiella pneumoniae-induced liver abscess and bacteremia. J Inflamm Res. 2021;14:777\u201389.","journal-title":"J Inflamm Res"},{"issue":"659\u2013670","key":"1629_CR14","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(659\u2013670): e5.","journal-title":"Cell Host Microbe"},{"key":"1629_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967\u201370.","journal-title":"Science"},{"key":"1629_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01967","author":"JZ Ye","year":"2018","unstructured":"Ye JZ, Lv LX, Wu WR, Li YT, Shi D, Fang DQ, et al. Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol. 2018. https:\/\/doi.org\/10.3389\/fmicb.2018.01967.","journal-title":"Front Microbiol"},{"key":"1629_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660312","volume":"12","author":"C Huang","year":"2021","unstructured":"Huang C, Shao J, Lou C, Wu F, Ge T, Gao H, et al. Reduced energy metabolism impairs t cell-dependent b cell responses in patients with advanced HBV-related cirrhosis. Front Immunol. 2021;12: 660312.","journal-title":"Front Immunol"},{"key":"1629_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577\u201384.","journal-title":"Nature"},{"key":"1629_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","volume":"128","author":"F Oakley","year":"2005","unstructured":"Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology. 2005;128:108\u201320.","journal-title":"Gastroenterology"},{"key":"1629_CR20","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3748\/wjg.v27.i24.3581","volume":"27","author":"QJ Han","year":"2021","unstructured":"Han QJ, Mu YL, Zhao HJ, Zhao RR, Guo QJ, Su YH, et al. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells. World J Gastroenterol. 2021;27:3581\u201394.","journal-title":"World J Gastroenterol"},{"key":"1629_CR21","unstructured":"Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology; 49."},{"key":"1629_CR22","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.4049\/jimmunol.174.12.8027","volume":"174","author":"MN Ajuebor","year":"2005","unstructured":"Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, et al. Lack of chemokine receptor ccr5 promotes murine fulminant liver failure by preventing the apoptosis of activated cd1d-restricted nkt cells. J Immunol. 2005;174:8027\u201337.","journal-title":"J Immunol"},{"key":"1629_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends cancer. 2019;5:822\u201334.","journal-title":"Trends cancer"},{"issue":"12","key":"1629_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends in cancer. 2019;5(12):822\u201334.","journal-title":"Trends in cancer"},{"key":"1629_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fphar.2020.00548","volume":"11","author":"YT Chan","year":"2020","unstructured":"Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era? Front Pharmacol. 2020;11:548.","journal-title":"Front Pharmacol"},{"key":"1629_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1172\/JCI1018","volume":"102","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin invest. 1998;102:538\u201349.","journal-title":"J Clin invest"},{"key":"1629_CR27","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1038\/s41598-017-05845-5","volume":"7","author":"HD Singh","year":"2017","unstructured":"Singh HD, Otano I, Rombouts K, Singh KP, Peppa D, Gill US, et al. TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis. Sci Rep. 2017;7:5514.","journal-title":"Sci Rep"},{"key":"1629_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496\u2013503.","journal-title":"Trends Biotechnol"},{"key":"1629_CR29","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/gb-2011-12-5-r50","volume":"12","author":"JG Caporaso","year":"2011","unstructured":"Caporaso JG, Lauber CL, Costello E. Moving pictures of the human microbiome. Genome Biol. 2011;12:R50.","journal-title":"Genome Biol"},{"key":"1629_CR30","unstructured":"Lavelle A, Lennon G, O\"Sullivan O, Docherty N, Balfe A, Maguire A, et al. 2015 Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut:gutjnl-2014\u2013307873."},{"key":"1629_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-2275(20)37444-7","volume":"38","author":"SK Cheema","year":"1997","unstructured":"Cheema SK, Cikaluk D, Agellon LB. Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression. J Lipid Res. 1997;38:315\u201323.","journal-title":"J Lipid Res"},{"key":"1629_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"MM Aydin","year":"2018","unstructured":"Aydin MM, Akcali KC. Liver fibrosis. Turkish J gastroenterology. 2018;29:14\u201321.","journal-title":"Turkish J gastroenterology"},{"key":"1629_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10620-019-05798-x","volume":"65","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhang Q, Kong Y, Guo X, Zhang H, Fan H, et al. Insulin-like growth factor binding protein-related protein 1 activates primary hepatic stellate cells via autophagy regulated by the pi3k\/akt\/mtor signaling pathway. Dig Dis Sci. 2020;65:509\u201323.","journal-title":"Dig Dis Sci"},{"key":"1629_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jhep.2013.04.029","volume":"59","author":"A Glassner","year":"2013","unstructured":"Glassner A, Eisenhardt M, Kokordelis P, Kramer B, Wolter F, Nischalke HD, et al. Impaired CD4(+) T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV\/HCV patients. J Hepatol. 2013;59:427\u201333.","journal-title":"J Hepatol"},{"key":"1629_CR35","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3748\/wjg.v27.i24.3581","volume":"27","author":"QJ Han","year":"2021","unstructured":"Han QJ, Mu YL, Zhao HJ, Zhao RR, Zhang J. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells. World J Gastroenterol. 2021;27:3581\u201394.","journal-title":"World J Gastroenterol"},{"key":"1629_CR36","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3389\/fimmu.2018.01572","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu L, Jin M, Tao Q, Yu L, Du J, Wang C, et al. Effective amelioration of liver fibrosis through lentiviral vector carrying toxoplasma gondii gra15ii in murine model. Front Immunol. 2018;9:1572.","journal-title":"Front Immunol"},{"key":"1629_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-020-20315-9","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tang B, Long L, Luo P, Xiang W, Li X, et al. Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nat Commun. 2021;12:102.","journal-title":"Nat Commun"},{"key":"1629_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7:678\u201393.","journal-title":"Nat Rev Drug Discov"},{"key":"1629_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102766","volume":"55","author":"M Wei","year":"2020","unstructured":"Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. 2020;55: 102766.","journal-title":"EBioMedicine"},{"key":"1629_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.614044","volume":"12","author":"X Zhu","year":"2021","unstructured":"Zhu X, Guo Q, Zou J, Wang B, Zhang Z, Wei R, et al. MiR-19a-3p suppresses m1 macrophage polarization by inhibiting stat1\/irf1 pathway. Front Pharmacol. 2021;12: 614044.","journal-title":"Front Pharmacol"},{"issue":"12","key":"1629_CR41","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/cells9122658","volume":"9","author":"S Reinhold","year":"2020","unstructured":"Reinhold S, Blankesteijn WM, Foulquier S. The Interplay of WNT and PPARgamma signaling in vascular calcification. Cells. 2020;9(12):2658.","journal-title":"Cells"},{"key":"1629_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.7150\/thno.9476","volume":"5","author":"SK Patel","year":"2015","unstructured":"Patel SK, Janjic JM. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases. Theranostics. 2015;5:150\u201372.","journal-title":"Theranostics"},{"key":"1629_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fnins.2020.00151","volume":"14","author":"M Lu","year":"2020","unstructured":"Lu M, He Y, Gong M, Li Q, Tang Q, Wang X, et al. Role of neuro-immune cross-talk in the anti-obesity effect of electro-acupuncture. Front Neurosci. 2020;14:151.","journal-title":"Front Neurosci"},{"key":"1629_CR44","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1089\/scd.2012.0442","volume":"22","author":"H Eto","year":"2013","unstructured":"Eto H, Ishimine H, Kinoshita K, Watanabe-Susaki K, Kato H, Doi K, et al. Characterization of human adipose tissue-resident hematopoietic cell populations reveals a novel macrophage subpopulation with CD34 expression and mesenchymal multipotency. Stem cells dev. 2013;22:985\u201397.","journal-title":"Stem cells dev"},{"key":"1629_CR45","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1111\/cas.13628","volume":"109","author":"B Delire","year":"2018","unstructured":"Delire B, Henriet P, Lemoine P, Leclercq IA, Starkel P. Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages. Cancer Sci. 2018;109:2141\u201352.","journal-title":"Cancer Sci"},{"key":"1629_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","volume":"7","author":"BP Keenan","year":"2019","unstructured":"Keenan BP, Fong L, Kelley RK. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. J Immunother Cancer. 2019;7:267.","journal-title":"J Immunother Cancer"},{"key":"1629_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13069-015-0036-7","volume":"8","author":"KM Irvine","year":"2015","unstructured":"Irvine KM, Clouston AD, Gadd VL, Miller GC, Wong WY, Melino M, et al. Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury. Fibrogenesis tissue repair. 2015;8:19.","journal-title":"Fibrogenesis tissue repair"},{"key":"1629_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195\u2013206.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1629_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med. 2018;215:383\u201396.","journal-title":"J Exp Med"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01629-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-022-01629-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01629-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T08:16:43Z","timestamp":1667117803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-022-01629-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":49,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1007\/s00011-022-01629-4","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"7 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Lithocholic acid (LCA) achieves anti-inflammatory and anti-fibrotic effects in the liver by regulating the differentiation of macrophages and inhibiting the activation of hepatic stellate cells (HSCs). The impacts of LCA on liver fibrosis need the synergistic effects of the gut microbiota.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution to the field statement"}},{"value":"The First Affiliated Hospital of Zhejiang University School of Medicine ethics committee approved these animal experiments in accordance with Helsinki ethics committee guidelines. Informed consent was obtained from all participants. The Ethics Committee approved the experimental protocol of the same hospital (V2.0\/20190503).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}